Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Spinal stimulation and robot suit aim to get people with paralysis walking better

NCT ID NCT05921175

Disease control Sponsor: National University Hospital, Singapore Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether adding transcutaneous spinal cord stimulation (tSCS) to robotic gait training (RGT) can improve trunk control and walking in people with chronic spinal cord injury. Twelve participants will first receive RGT alone, then RGT plus tSCS, and their progress will be measured. The goal is to see if the combination leads to better mobility and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcutaneous spinal cord stimulation (tSCS) plus robotic gait training
What this could lead to
If it works, this could point toward a way to improve trunk control and walking ability in people with chronic spinal cord injury.
What could go wrong
This is a very small pilot study (12 people) with no control group, so results may not be generalizable. The added benefit of tSCS over robotic training alone is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 6 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Between 6 months to 5 years from the diagnosis of the traumatic SCI and who are not walking independently; 2. Age between 21 to 65 years old; 3. Incomplete spinal cord injury: ASIA Impairment Scale (AIS) Grade: B-D; 4. Spinal cord injury level: T1- L1, or C2-C8; 5. SCI-TCT Score \> 13; 6. Capable of providing an informed consent; 7. Cleared by Neurosurgeons/ Orthopeadic Surgeons for tSCS; 8. Meets prerequisites for Ekso wearable robotic exoskeleton training. Exclusion Criteria: 1. Participant has uncontrolled cardiopulmonary disease or cardiac symptoms as determined by the investigator; 2. Participant has any unstable or significant medical condition that is likely to interfere with study procedures or likely to confound performance and outcomes like uncontrolled neuropathic pain, depression, severe cognitive impairment; 3. Unstable or uncontrolled autonomic dysreflexia; 4. Requires ventilator support; 5. Spasms that limit the ability of the subjects to participate in the study training as determined by the investigator; 6. Skin conditions that limit the application of tSCS electrodes; 7. Active implanted medical devices that may be affected by tSCS; 8. Pregnant, planning to become pregnant or breastfeeding; 9. Concurrent participation in another drug or device trial that may interfere with this study; 10. Participated in wearable exoskeleton training within the last 3 months prior to enrolment. 11. Peripheral nerve injury or significant Lumbar Radiculopathy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal cord injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spinal cord injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Alexandra Hospital

    RECRUITING

    Singapore, Singapore, 159964, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.